QuantuMDx is launching its first recruitment drive in the North East, as they seek to fill a range of scientific positions to develop its groundbreaking technologies . 03/05/2012
The biotech company, which relocated in August last year, want to recruit nine scientists, including six PhD level candidates, with expertise in molecular biology, chemistry and engineering. The company has agreed to sponsor a number of PhD and MSc posts jointly with Newcastle University .
Elaine Warburton, chief executive officer of QuantuMDx said, ‘It was the international reputation of Newcastle University’s Biomedicine faculty that attracted us to the city. Particularly the Institute of Genetics’ work in genotyping and gene sequencing led by Professor Sir John Burn, who is our medical director. We’re absolutely delighted to be in a position to commence recruiting from the pool of top class scientific talent within the area.'
The new recruits will help to develop and commercialise the company’s first product called Q-POC™ (QuantuMDx point of care). A low cost, handheld DNA diagnostic and sequencing device much like a smartphone or an iphone.
Invented by QuantuMDx’s chief scientific officer Jonathan O’Halloran, it will accurately diagnose complex diseases and the correct drug to prescribe, in less than 20 minutes at the patient’s side. This will require just a tiny sample like a pinprick of blood or a few drops of sputum or urine.
This website is best viewed in an up-to-date web browser with CSS enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets if you are able to do so.